Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Investor Presentation (November 2020)
42 slides from Balaji Amines's investor presentation, Nov 4, 2020
Slide 1: Exchange filing cover letter: Investor Presentation
1S 9001:2015 a ae : wowituvcom aes 10 9105038797 CIN : L24132MH1988PLC049387 TEL : 0091-217 - 2310824 AMINES LIMITED ZA 21M REGD. OFF. : 'BALAJI TOWERS’, FAX =: 0091-217- 2451521 No. 9/1A/1, HOTGI ROAD, E-MAIL _ : info@balajiamines.com AASARA CHOWK, SOLAPUR - 413 224, WEBSITE: http://www.balajiamine
Slide 2: Balaji Amines Limited Investor Presentation – November 2020
Balaji Amines Limited Investor Presentation – November 2020
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Q2FY21: Standalone Performance Highlights
Q2FY21: Standalone Performance Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) Margin 20.82% 25.12% 25.49% 14.88% 16.27% 16.82% 21.43% 48.69% 37.31% 283.28 72.22 47.66 233.28 212.97 53.50 34.71 34.65 48.57 Q2FY20 Q1FY21 Q2FY21 Q2FY20 Q1FY21 Q2FY21 Q2FY20 Q1FY21 Q2FY21 3
Slide 5: H1FY21: Performance Highlights
H1FY21: Performance Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) Margin 18.83% 25.33% 11.71% 16.59% 6.26% +42.93% +50.56% 496.25 125.72 82.31 467.01 87.96 54.67 H1FY20 H1FY21 H1FY20 H1FY21 H1FY20 H1FY21 4
Slide 6: Q2FY21 Performance Highlights
Q2FY21 Performance Highlights Sales volumes were up by 8.30% from 21,376 MT in Q2FY20 to 23,150 MT in Q2FY21. Our plants’ capacity utilization in Q2 was similar to pre-COVID levels. We witnessed an increase in demand across our product portfolio with improved price realizations. Our EBIDTA margins i
Slide 7: Expansion Plans
Expansion Plans Acetonitrile Ethylamines & DMC Methylamines Dimethyl Formamide ❑ Have installed capacity of 9,000 ton ❑ Have installed capacity of 6,000 TPA ❑ Market Leader in Methylamines ❑ Market Leader in Dimethyl per annum (TPA). Currently ❑ Under the phase-1 of Greenfield production in India wi
Slide 8: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q2FY21 Q2FY20 Y-o-Y H2FY20 H1FY20 Y-o-Y Total Revenue 283.28 233.28 21.43% 496.25 467.01 6.26% Raw Material 147.36 128.12 259.04 269.47 Employee expense 15.14 11.49 25.97 22.21 Other expenses 48.56 45.10 85.52 87.37 EBITDA 72.22 48.57
Slide 9: Standalone Balance Sheet Statement
Standalone Balance Sheet Statement ASSETS (Rs. Crs.) Sep-20 Mar-20 EQUITY AND LIABILITIES (Rs. Crs.) Sep-20 Mar-20 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 352.16 363.40 (a) Equity Share capital 6.48 6.48 (b) Other equity 742.01 661.16 (b) Capital work-in-progress 98.65 44.63 Su
Slide 10: About Us
at AMINES About Us
Slide 11: Amines Industry – Unique but Critical Industry with growth potential
Amines Industry – Unique but Critical Industry with growth potential The size of Aliphatic Amines industry globally is For Indian Amine manufacturers, 45-55% of the $4.9 billion. Globally, the Amine industry is export revenue comes from Europe alone. USA 8 1 oligopolistic with two-three producers ca
Slide 12: Balaji Amines Ltd – A Leading player in Aliphatic Amines in India
Balaji Amines Ltd – A Leading player in Aliphatic Amines in India Largest manufacturer of Aliphatic State-of-the-art manufacturing 25+ Product basket Zero Liquid Discharge Amines in India facilities fully equipped with latest DCS technology facilities Only Company to develop an Indigenous Technology
Slide 13: Our Products are supplied to India’s fast-growing Industries
Our Products are supplied to India’s fast-growing Industries INDUSTRY WISE – REVENUE BREAKUP 3% 4% 3% 4% PHARMA AGRO-CHEMICALS ANIMAL FEEDS 3% 2% 4% 51% PAINTS & RESINS OIL & GAS RUBBER CLEANING CHEMICALS 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Trea
Slide 14: Highly Experienced Management Team
Highly Experienced Management Team Mr. A. Srinivas Reddy Mr. D. Ram Reddy Mr. A. Pratap Reddy Mr. N. Rajeshwar Reddy Mr. G. Hemanth Reddy Whole Time Director Managing Director Executive Chairman Joint Managing Director Whole Time Director & CFO • Post Graduate in Computer • 35 years of experience ac
Slide 15: Diversified Product Portfolio
Diversified Product Portfolio Amines Amine Derivatives Specialty & Other Chemicals • Aliphatic Amines find increasing consumption and • Amine Derivatives are used to make further salts and • Albeit a small and fastest growing segment applications in a Chemically mature Industry such other complex ch
Slide 16: Clientele
Clientele Amines Amine Derivatives Specialty & Other Chemicals The company logos mentioned above are the property of their respective owners and are used here for identification purposes only 15
Slide 17: Well positioned Business Model aimed at Sustainable growth
Well positioned Business Model aimed at Sustainable growth Focus towards high-value derivatives and Develop new indigenous technology for specialty chemicals with an aim to move up manufacturing products leading to lowering in the value-chain with vertical integration manufacturing costs & improving
Slide 18: Key Products (Current & Proposed) in Portfolio
Key Products (Current & Proposed) in Portfolio Balaji Amines In MTPA Balaji Speciality Chemicals In MTPA Installed Future Installed Product Application Areas Product Application Areas Capacity Capacity Capacity Ethylenediamine 37,350 Pesticides, Polymers Methyl Amine 48,000 50,000 Pharma, Agro, Dye
Slide 19: We are Global suppliers – a significant validation of our Capabilities
We are Global suppliers – a significant validation of our Capabilities 19.11% of the Total Revenue for FY20 i.e. Rs. 177.56 Crore is generated from exports spanning across continents Note: Maps not to scale. All data, information, and maps are provided "as is" without warranty or any representation
Slide 20: Awards & Certificates – A Testimony of our capabilities (1/2)
Awards & Certificates – A Testimony of our capabilities (1/2) ISO Certificate Two Star Export House ISO Certificate ISO 9001 : 2015 Certificate Certificate of Merit – CHEMEXCIL First Award – CHEMEXCIL 19
Slide 21: Awards & Certificates – A Testimony of our capabilities (2/2)
Awards & Certificates – A Testimony of our capabilities (2/2) Product Innovator of Distinguished Contribution Excellent CSR in Water the Year in Chemicals – in the Indian Chemicals Conservation 2018 Industry WHO GMP Certificate REACH Pre-Registration Niryat Shree Award by FIEO 20
Slide 22: We are Growing…Sustainably and Consistently
We are Growing…Sustainably and Consistently “Long-Term Issuer Rating affirmed at ‘IND AA-’ by India Ratings and Research (Ind-Ra) .” The ratings process highlighted the following factors:- • Largest manufacturer of aliphatic amines and their derivatives in India • Increased product offtake and meani
Slide 23: High entry barrier Business – Paving way for Sustainable growth
High entry barrier Business – Paving way for Sustainable growth Complex Manufacturing High Lead time Capex Heavy Business Complex manufacturing process Niche product offering with high High fixed costs, with fixed asset requiring high levels of lead time in customer approvals turns hovering in the r
Slide 24: Well positioned Business Model aimed at Sustainable growth
Well positioned Business Model aimed at Sustainable growth Value-Added Products Applicability in Solvents segment Capex towards high-value derivatives and specialty Solvents account for 80%-90% of the mass chemicals will materialize into higher revenue and enhanced margins 01 utilised in a typical p
Slide 25: Greenfield Project to fuel growth and add Revenue Visibility
Greenfield Project to fuel growth and add Revenue Visibility Strategically Mega Project Project Capex Product Profile Indigenous New Products = 1st High Demand Located Plant Status Technology mover advantage for Products Environmental Phase-1 of Project cost of Rs. Plan to Plan to deploy Significant
Slide 26: Balaji Speciality Chemicals – Production commenced in H2FY20
Balaji Speciality Chemicals – Production commenced in H2FY20 Manufacturing products such Undertook capex of about Rs. Received Mega project status as Ethylene Diamine, 250 crore; loan contribution of for the Project from 01 Piperazine, 02 Rs. 150 crore . Expected 03 Maharashtra State Aminoethylpiper
Slide 27: R&D led Investments to provide significant early mover advantage
R&D led Investments to provide significant early mover advantage Environment Conscious New Products Identification of new products and Waste water treatment and minimization of effluents development of latest process by adopting Industry best practices for effluent technologies treatment. Efficiency
Slide 28: Hotel Division
at AMINES Hotel Division
Slide 29: Balaji Sarovar Premiere (Solapur)
Balaji Sarovar Premiere – Best in class Business Hotel in Solapur Balaji Sarovar Premiere (Solapur) 28
Slide 30: Balaji Sarovar Premiere – At a Glance
Balaji Sarovar Premiere – At a Glance • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Reve
Slide 31: Balaji Sarovar Premiere – Operating Matrix (FY20)
Balaji Sarovar Premiere – Operating Matrix (FY20) 129 Rooms Constitutes 2.20% Rs. 3,452 ARR of Total Revenue 58% Occupancy Rate Balaji Negligible Routine Capex incurred Sarovar RS. 1,994 RevPAR Premiere Renowned Five Star Hotel In the City of Solapur ARR : Average Room Revenue RevPAR: Revenue per Av
Slide 32: Financial Performance
at AMINES Financial Performance
Slide 33: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) +10% +14% +10% 943 941 190 193 186 113 117 861 153 97 643 670 82 127 58 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 EBITDA Margin (%) PAT Margin (%) RoE (%) 22.8% 22.0% 13.1% 22.7%
Slide 34: Strong Core RoCE Profile
Strong Core RoCE Profile Particulars (Rs. Crs.) FY19 FY20 ▪ Investments made to the tune of Rs. 112.35 crore in subsidiary Standalone Debt 94.83 102.36 company of Balaji Amines not considered, as the volume offtake Standalone Networth 575.00 667.64 was limited in FY20, since our clients has prior co
Slide 35: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q2FY21 Q2FY20 Y-o-Y FY20 FY19 Y-o-Y Total Revenue 283.28 233.28 21.43% 929.32 955.05 -2.69% Raw Material 147.36 128.12 511.18 522.20 Employee expense 15.14 11.49 49.62 48.28 Other expenses 48.56 45.10 178.50 185.95 EBITDA 72.22 48.57 4
Slide 36: Standalone Balance Sheet Statement
Standalone Balance Sheet Statement ASSETS (Rs. Crs.) Mar-20 Mar-19 EQUITY AND LIABILITIES (Rs. Crs.) Mar-20 Mar-19 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 363.40 318.35 (a) Equity Share capital 6.48 6.48 (b) Capital work-in-progress 44.63 63.24 (b) Other equity 661.16 568.52 (c
Slide 37: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars (in Rs. Crore) FY20 FY19 YoY Total Revenue 940.79 947.28 -0.69% Raw Material 513.83 515.35 Employee Cost 50.99 48.28 Other Expenses 190.21 186.01 EBITDA 185.76 197.64 -6.01% EBITDA Margin 19.75% 20.86% Depreciation 31.62 19.55 EBIT 154.14 178.09 -13.45%
Slide 38: Consolidated Balance Sheet Statement
Consolidated Balance Sheet Statement ASSETS (Rs. Crore) Mar-20 Mar-19 EQUITY AND LIABILITIES (Rs. Crore) Mar-20 Mar-19 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 573.00 319.75 (a) Equity Share capital 6.48 6.48 (b) Capital work-in-progress 44.63 269.46 (b) Other equity 651.66 567.
Slide 39: Consistent Dividend Payout
Consistent Dividend Payout 160% 140% 130% 110% 100% FY16 FY17 FY18 FY19 FY20 Particulars (Rs. per share) FY16 FY17 FY18 FY19 FY20 Consolidated Book Value 88.89 111.87 149.71 182.71 206.28 Consolidated EPS 17.78 25.42 34.93 36.27 32.34 Dividend 2.00 2.20 2.60 2.80 3.20 38
Slide 40: Moving towards Growth Prospects
Moving towards Growth Prospects
Slide 41: Balaji Amines Ltd - Progressing steadily
Balaji Amines Ltd - Progressing steadily Capex Phase Brownfield Expansion Subsidiary Expansion Greenfield Manufacturing of new products such Expansion and commercialization of Capex for Phase 1 of Greenfield Moving to higher margin niche as Ethylene Diamine, Piperazine and 90-acre project in MIDC Ch
Slide 42: For further information, please contact
For further information, please contact: Company : Investor Relations Advisors : Strategic Growth Advisors Pvt. Ltd. Balaji Amines Ltd. CIN - U74140MH2010PTC204285 CIN - L24132MH1988PLC049387 Mr. Shogun Jain / Mr. Parin Narichania Email - info@balajiamines.com shogun.jain@sgapl.net / parin.n@sgapl.n
Balaji Amines — Investor Presentation (November 2020) on 6ix